West Pharmaceutical Services, Inc. Common Stock (WST)
302.40
-9.67 (-3.10%)
NYSE· Last Trade: May 13th, 5:48 PM EDT
Detailed Quote
Previous Close
312.07
Open
310.44
Bid
259.78
Ask
314.52
Day's Range
300.27 - 310.49
52 Week Range
202.79 - 330.88
Volume
718,342
Market Cap
21.77B
PE Ratio (TTM)
44.54
EPS (TTM)
6.8
Dividend & Yield
0.8800 (0.29%)
1 Month Average Volume
1,025,163
Chart
About West Pharmaceutical Services, Inc. Common Stock (WST)
West Pharmaceutical Services is a prominent global leader in the design and manufacturing of components and systems for the delivery of injectable drugs. The company specializes in producing high-quality materials such as stoppers, seals, and prefillable syringes, which are essential for the safe and efficient administration of pharmaceuticals. West Pharmaceutical Services partners with pharmaceutical and biotechnology companies to deliver innovative solutions that enhance drug efficacy and patient safety, focusing on advancing healthcare through its cutting-edge technologies and services. With a commitment to excellence and a strong emphasis on sustainability, West continually strives to improve the standards of drug delivery within the healthcare industry. Read More
A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face c...
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recentl...
West Pharmaceutical Services delivered a first quarter that exceeded Wall Street's expectations, driven by robust demand for its high-value product (HVP) com...
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorab...
Healthcare products company West Pharmaceutical Services (NYSE:WST) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 21% year...
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a ne...
Healthcare products company West Pharmaceutical Services (NYSE:WST) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 21% year on year to $...
Healthcare products company West Pharmaceutical Services (NYSE:WST) will be reporting earnings this Thursday morning. Here’s what to expect. West Pharmaceuti...
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they strugg...
Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expecta...
Shares of West Pharmaceutical Services (NYSE: WST) tumbled 5.7% on Tuesday following the announcement that Eric Green, the company’s President, Chief Executive Officer, and Chair of the Board, intends to retire. The decline, which wiped out significant market capitalization in a single session, reflects investor anxiety over the
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how drug development ...
